Compagnie Lombard Odier SCmA’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-1,500
| Closed | -$5K | – | 733 |
|
|
2017
Q2 | $5K | Hold |
1,500
| – | – | ﹤0.01% | 672 |
|
|
2017
Q1 | $14K | Hold |
1,500
| – | – | ﹤0.01% | 654 |
|
|
2016
Q4 | $12K | Hold |
1,500
| – | – | ﹤0.01% | 745 |
|
|
2016
Q3 | $17K | Hold |
1,500
| – | – | ﹤0.01% | 800 |
|
|
2016
Q2 | $18K | Hold |
1,500
| – | – | ﹤0.01% | 789 |
|
|
2016
Q1 | $15K | Hold |
1,500
| – | – | ﹤0.01% | 848 |
|
|
2015
Q4 | $34K | Hold |
1,500
| – | – | ﹤0.01% | 737 |
|
|
2015
Q3 | $25K | Hold |
1,500
| – | – | ﹤0.01% | 677 |
|
|
2015
Q2 | $34K | Hold |
1,500
| – | – | ﹤0.01% | 669 |
|
|
2015
Q1 | $39K | Hold |
1,500
| – | – | ﹤0.01% | 806 |
|
|
2014
Q4 | $33K | Hold |
1,500
| – | – | ﹤0.01% | 660 |
|
|
2014
Q3 | $28K | Hold |
1,500
| – | – | ﹤0.01% | 769 |
|
|
2014
Q2 | $35K | Hold |
1,500
| – | – | ﹤0.01% | 777 |
|
|
2014
Q1 | $50K | Hold |
1,500
| – | – | ﹤0.01% | 724 |
|
|
2013
Q4 | $44K | Buy |
+1,500
| New | +$44K | ﹤0.01% | 721 |
|